Levente Bodoki

800 total citations
28 papers, 428 citations indexed

About

Levente Bodoki is a scholar working on Epidemiology, Molecular Biology and Dermatology. According to data from OpenAlex, Levente Bodoki has authored 28 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 10 papers in Molecular Biology and 9 papers in Dermatology. Recurrent topics in Levente Bodoki's work include Inflammatory Myopathies and Dermatomyositis (23 papers), Skin Diseases and Diabetes (9 papers) and Muscle Physiology and Disorders (8 papers). Levente Bodoki is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (23 papers), Skin Diseases and Diabetes (9 papers) and Muscle Physiology and Disorders (8 papers). Levente Bodoki collaborates with scholars based in Hungary, United Kingdom and Norway. Levente Bodoki's co-authors include Katalin Dankó, Melinda Nagy‐Vincze, Zoltán Griger, Zoë Betteridge, Hector Chinoy, James B Lilleker, Gavin Shaddick, Louise Ekholm, Robert G. Cooper and Neil McHugh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and BioMed Research International.

In The Last Decade

Levente Bodoki

28 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Levente Bodoki Hungary 8 333 225 111 75 68 28 428
Melinda Nagy‐Vincze Hungary 9 357 1.1× 232 1.0× 97 0.9× 81 1.1× 59 0.9× 26 420
Damien Amelin France 5 372 1.1× 149 0.7× 134 1.2× 64 0.9× 84 1.2× 9 433
Xiaolan Tian China 11 237 0.7× 170 0.8× 68 0.6× 60 0.8× 126 1.9× 23 375
Kenzo Kaji Japan 8 424 1.3× 226 1.0× 83 0.7× 90 1.2× 80 1.2× 15 527
Masaomi Yamasaki Japan 8 396 1.2× 276 1.2× 91 0.8× 90 1.2× 61 0.9× 11 542
Lenka Pleštilová Czechia 12 227 0.7× 152 0.7× 181 1.6× 38 0.5× 147 2.2× 23 420
Laura Gutierrez‐Alamillo United States 6 157 0.5× 116 0.5× 73 0.7× 47 0.6× 54 0.8× 13 290
Angeles S. Galindo‐Feria Sweden 10 191 0.6× 76 0.3× 68 0.6× 38 0.5× 73 1.1× 21 264
Jana Tomasová Studýnková Czechia 7 224 0.7× 129 0.6× 80 0.7× 38 0.5× 54 0.8× 7 327
Anke Rietveld Netherlands 7 206 0.6× 144 0.6× 64 0.6× 35 0.5× 97 1.4× 11 309

Countries citing papers authored by Levente Bodoki

Since Specialization
Citations

This map shows the geographic impact of Levente Bodoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levente Bodoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levente Bodoki more than expected).

Fields of papers citing papers by Levente Bodoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levente Bodoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levente Bodoki. The network helps show where Levente Bodoki may publish in the future.

Co-authorship network of co-authors of Levente Bodoki

This figure shows the co-authorship network connecting the top 25 collaborators of Levente Bodoki. A scholar is included among the top collaborators of Levente Bodoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levente Bodoki. Levente Bodoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bodoki, Levente, Attila Makai, Zsuzsanna Orosz, et al.. (2023). Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience. Frontiers in Oncology. 13. 1252215–1252215. 5 indexed citations
2.
Nagy‐Vincze, Melinda, Zoltán Griger, Katalin Dankó, et al.. (2023). Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases. Autoimmunity Reviews. 22(5). 103311–103311. 3 indexed citations
3.
Szabó, Katalin, Levente Bodoki, Melinda Nagy‐Vincze, et al.. (2022). Clinical, Serological, and Genetic Characteristics of a Hungarian Myositis‐Scleroderma Overlap Cohort. BioMed Research International. 2022(1). 6251232–6251232. 3 indexed citations
4.
Szekanecz, Zoltán, Boglárka Soós, Levente Bodoki, et al.. (2020). Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases. Autoimmunity Reviews. 19(11). 102658–102658. 14 indexed citations
5.
Bodoki, Levente, Katalin Szabó, Melinda Nagy‐Vincze, et al.. (2020). The risk of fracture and prevalence of osteoporosis is elevated in patients with idiopathic inflammatory myopathies: cross-sectional study from a single Hungarian center. BMC Musculoskeletal Disorders. 21(1). 426–426. 10 indexed citations
6.
Bodoki, Levente, Zoltán Griger, Melinda Nagy‐Vincze, Zoë Betteridge, & Katalin Dankó. (2020). AB0552 CHARACTERISTICS OF MYOSITIS SPECTRUM DISEASE - RHEUMATOID ARTHRITIS OVERLAP CASES IN A HUNGARIAN COHORT. Annals of the Rheumatic Diseases. 79. 1572–1572. 1 indexed citations
7.
Betteridge, Zoë, Sarah Tansley, Gavin Shaddick, et al.. (2019). Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. Journal of Autoimmunity. 101. 48–55. 180 indexed citations
8.
András, Csilla, et al.. (2019). Retrospective Analysis of Cancer-Associated Myositis Patients over the Past 3 Decades in a Hungarian Myositis Cohort. Pathology & Oncology Research. 26(3). 1749–1755. 31 indexed citations
9.
Végh, Edit, György Kerekes, Attila Hamar, et al.. (2019). Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis. Rheumatology International. 40(3). 427–436. 29 indexed citations
10.
Bodoki, Levente, et al.. (2018). Rare myositis-specific autoantibody associations among Hungarian patients with idiopathic inflammatory myopathy.. PubMed. 40(4). 337–47. 4 indexed citations
11.
Szabó, Katalin, Levente Bodoki, Melinda Nagy‐Vincze, et al.. (2018). Effect of Genetic and Laboratory Findings on Clinical Course of Antisynthetase Syndrome in a Hungarian Cohort. BioMed Research International. 2018. 1–9. 7 indexed citations
12.
Szabó, Katalin, Melinda Nagy‐Vincze, Levente Bodoki, et al.. (2016). Az anti-Jo-1-pozitív antiszintetáz szindróma jellegzetességei gondozott betegeink alapján. Orvosi Hetilap. 157(15). 575–583. 1 indexed citations
13.
Bodoki, Levente, Melinda Nagy‐Vincze, Zoltán Griger, & Katalin Dankó. (2015). Dermatomyositisspezifische Antikörper. Zeitschrift für Rheumatologie. 74(4). 363–369. 1 indexed citations
14.
Murnyák, Balázs, Levente Bodoki, Zoltán Griger, et al.. (2015). Inclusion body myositis – pathomechanism and lessons from genetics. SHILAP Revista de lepidopterología. 10(1). 188–193. 4 indexed citations
15.
16.
17.
Bodoki, Levente, Melinda Nagy‐Vincze, Zoltán Griger, Andrea Péter, & Katalin Dankó. (2014). The association of colitis ulcerosa and coeliakia with idiopathic inflammatory myopathy. Orvosi Hetilap. 155(26). 1033–1038. 5 indexed citations
18.
Bodoki, Levente, Zoltán Griger, Tamás Csonka, et al.. (2013). Inclusion body myositis — a case based clinicopathological update. SHILAP Revista de lepidopterología. 9(1). 80–85. 1 indexed citations
19.
Bodoki, Levente, et al.. (2013). Intravenous immunoglobulin treatment in idiopathic inflammatory myopathy. Orvosi Hetilap. 154(19). 723–728. 1 indexed citations
20.
Bodoki, Levente, et al.. (2012). Necrotizing autoimmune myopathy. Orvosi Hetilap. 153(38). 1502–1507. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melinda Nagy‐Vincze Breakdown of academic impact, for papers by Damien Amelin Breakdown of academic impact, for papers by Xiaolan Tian Breakdown of academic impact, for papers by Kenzo Kaji Breakdown of academic impact, for papers by Masaomi Yamasaki Breakdown of academic impact, for papers by Lenka Pleštilová Breakdown of academic impact, for papers by Laura Gutierrez‐Alamillo Breakdown of academic impact, for papers by Angeles S. Galindo‐Feria Breakdown of academic impact, for papers by Jana Tomasová Studýnková Breakdown of academic impact, for papers by Anke Rietveld
Rankless by CCL
2026